Baker Brothers Advisors - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 48 filers reported holding ENTRADA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$76,879,940
+4.4%
4,865,8190.0%0.44%
+4.0%
Q2 2023$73,668,500
+4.4%
4,865,8190.0%0.43%
+10.9%
Q1 2023$70,554,376
+7.2%
4,865,8190.0%0.38%
-2.8%
Q4 2022$65,785,873
-14.2%
4,865,8190.0%0.40%
-21.3%
Q3 2022$76,685,000
+29.4%
4,865,8190.0%0.50%
+49.4%
Q2 2022$59,266,000
+34.2%
4,865,819
+3.4%
0.34%
+32.3%
Q1 2022$44,174,000
-45.2%
4,704,4190.0%0.25%
-35.2%
Q4 2021$80,540,0004,704,4190.39%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,425,784$64,173,86826.74%
5AM Venture Management, LLC 4,408,379$63,921,49616.35%
72 Investment Holdings, LLC 509,023$7,380,8333.50%
StepStone Group LP 761,277$11,038,5172.05%
TCG Crossover Management, LLC 584,955$8,481,8481.65%
Redmile Group, LLC 1,831,608$26,558,3161.15%
Nan Fung Group Holdings Ltd 73,582$1,066,9390.73%
Baker Brothers Advisors 4,865,819$70,554,3760.38%
CHI Advisors LLC 56,374$817,4230.22%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,522,5000.03%
View complete list of ENTRADA THERAPEUTICS INC shareholders